Sign up to save your podcasts
Or
Share 055: Solving the Licensing and Regulatory Challenges for Canna-Businesses with Dr. Sherry Boodram
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
055: Solving the Licensing and Regulatory Challenges for Canna-Businesses with Dr. Sherry Boodram
With so many new markets coming online in the next few years, there are more people than ever before looking for help with permitting, licensing, and everything else that comes with launching a business in a highly regulated industry.
When they need that help, they turn to people like today's guest, Dr. Sherry Boodram. She's the CEO and co-founder of CannDelta–a regulatory and scientific consulting company that helps clients navigate both the cannabis and psychedelic industries. Dr. Boodram and her team provide regulatory compliance advice to operate in the legal Canadian markets, and they also provide support to international jurisdictions, including the U.S.
Before launching CannDelta, she was actually a part of the Canadian federal government, serving as Health Canada's Medical Cannabis and Controlled Substances Programs' Senior Regulatory Compliance and Enforcement Officer. She holds a Ph.D in Chemistry, an honorary B.S. in Biological Chemistry, and certificates in Cannabis Law and Regulation as well as Pharmaceutical Regulatory Affairs and Quality Operations.
In this conversation, Sherry walks us through the hoops and hurdles facing people looking to break into the cannabis and psychedelics industries, the mistakes so many people make while trying to ensure that they're operating legally, and the key differences between the established Canadian and emerging American markets.
KEY TAKEAWAYS
- The most common mistakes that people make when trying to get cannabis licenses.
- Why Shelly transitioned out of government to launch CannDelta–and what she's focused on now.
- The unique benefits of working with someone who knows Canada's industry so well for anyone planning a launch in a state like New York or New Jersey.
- Why medical approvals for psilocybin in a number of states are more likely to happen now than ever before.
- Why social equity has to be such a big part of the American cannabis story–and how Canada failed to integrate First Nations peoples into its legalization.
Show Notes
For complete show notes, including transcripts, takeaways, and links to all the resources mentioned, visit SoHoExp.com/55
To learn more about the podcast and get access to all episodes, visit: SoHoExp.com/GreenRepeal
View all episodes
By Rick Kiley Jeffrey Boedges
4.8
1313 ratings
With so many new markets coming online in the next few years, there are more people than ever before looking for help with permitting, licensing, and everything else that comes with launching a business in a highly regulated industry.
When they need that help, they turn to people like today's guest, Dr. Sherry Boodram. She's the CEO and co-founder of CannDelta–a regulatory and scientific consulting company that helps clients navigate both the cannabis and psychedelic industries. Dr. Boodram and her team provide regulatory compliance advice to operate in the legal Canadian markets, and they also provide support to international jurisdictions, including the U.S.
Before launching CannDelta, she was actually a part of the Canadian federal government, serving as Health Canada's Medical Cannabis and Controlled Substances Programs' Senior Regulatory Compliance and Enforcement Officer. She holds a Ph.D in Chemistry, an honorary B.S. in Biological Chemistry, and certificates in Cannabis Law and Regulation as well as Pharmaceutical Regulatory Affairs and Quality Operations.
In this conversation, Sherry walks us through the hoops and hurdles facing people looking to break into the cannabis and psychedelics industries, the mistakes so many people make while trying to ensure that they're operating legally, and the key differences between the established Canadian and emerging American markets.
KEY TAKEAWAYS
- The most common mistakes that people make when trying to get cannabis licenses.
- Why Shelly transitioned out of government to launch CannDelta–and what she's focused on now.
- The unique benefits of working with someone who knows Canada's industry so well for anyone planning a launch in a state like New York or New Jersey.
- Why medical approvals for psilocybin in a number of states are more likely to happen now than ever before.
- Why social equity has to be such a big part of the American cannabis story–and how Canada failed to integrate First Nations peoples into its legalization.
Show Notes
For complete show notes, including transcripts, takeaways, and links to all the resources mentioned, visit SoHoExp.com/55
To learn more about the podcast and get access to all episodes, visit: SoHoExp.com/GreenRepeal